Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OxyBand Technologies has appointed Olivier Postel as its new chief technology officer to lead the company's biomedical technology development and expand its intellectual property portfolio.
Subscribe to our email newsletter
Prior to joining OxyBand, Mr Postel was the director of process engineering and integration at dpiX.
Mr Postel has served on an NIH review committee on infectious diseases and microbiology for the past several years. He has also worked with other Silicon Valley start-ups of various stages in developing technology.
Amie Franklin, CEO of OxyBand, said: “We are very pleased Olivier has joined our team and we hope to capitalize on his expertise in therapeutic gas science and technology, and product development to enter the market quickly.”